Clinical Evaluation of a Metagenomics-Based Assay for Pneumonia Management

Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for bot...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in microbiology Vol. 12; p. 751073
Main Authors Zhan, Yangqing, Xu, Teng, He, Fusheng, Guan, Wei-jie, Li, Zhengtu, Li, Shaoqiang, Xie, Mingzhou, Li, Xiaolei, Chen, Rongchang, Cheng, Linling, Zhong, Nanshan, Ye, Feng
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 16.09.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for both etiological and clinical impact investigation in pneumonia was assessed. Among the 276 potential pathogens detected with PneumoSeq in our cohort, 251 (90.9%) were cross-validated. Clinical diagnoses of the causative pathogens were obtained for 97 patients, 90.7% of which were supported by PneumoSeq. Compared to conventional testing, PneumoSeq suggested potentially missed diagnoses in 16.7% of cases (22/132), involving 48 additional pathogenic microorganisms. In 58 (43.9%) cases, PneumoSeq data led to antimicrobial treatment de-escalation ( n = 12 in ICO, n = 18 in ICH) and targeted treatment initiation ( n = 7 in ICO, n = 21 in ICH). The PneumoSeq assay benefited the diagnosis and clinical management of both ICH and ICO pneumonia patients in real-world settings.
AbstractList Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for both etiological and clinical impact investigation in pneumonia was assessed. Among the 276 potential pathogens detected with PneumoSeq in our cohort, 251 (90.9%) were cross-validated. Clinical diagnoses of the causative pathogens were obtained for 97 patients, 90.7% of which were supported by PneumoSeq. Compared to conventional testing, PneumoSeq suggested potentially missed diagnoses in 16.7% of cases (22/132), involving 48 additional pathogenic microorganisms. In 58 (43.9%) cases, PneumoSeq data led to antimicrobial treatment de-escalation (n = 12 in ICO, n = 18 in ICH) and targeted treatment initiation (n = 7 in ICO, n = 21 in ICH). The PneumoSeq assay benefited the diagnosis and clinical management of both ICH and ICO pneumonia patients in real-world settings.
Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for both etiological and clinical impact investigation in pneumonia was assessed. Among the 276 potential pathogens detected with PneumoSeq in our cohort, 251 (90.9%) were cross-validated. Clinical diagnoses of the causative pathogens were obtained for 97 patients, 90.7% of which were supported by PneumoSeq. Compared to conventional testing, PneumoSeq suggested potentially missed diagnoses in 16.7% of cases (22/132), involving 48 additional pathogenic microorganisms. In 58 (43.9%) cases, PneumoSeq data led to antimicrobial treatment de-escalation ( n = 12 in ICO, n = 18 in ICH) and targeted treatment initiation ( n = 7 in ICO, n = 21 in ICH). The PneumoSeq assay benefited the diagnosis and clinical management of both ICH and ICO pneumonia patients in real-world settings.
Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for both etiological and clinical impact investigation in pneumonia was assessed. Among the 276 potential pathogens detected with PneumoSeq in our cohort, 251 (90.9%) were cross-validated. Clinical diagnoses of the causative pathogens were obtained for 97 patients, 90.7% of which were supported by PneumoSeq. Compared to conventional testing, PneumoSeq suggested potentially missed diagnoses in 16.7% of cases (22/132), involving 48 additional pathogenic microorganisms. In 58 (43.9%) cases, PneumoSeq data led to antimicrobial treatment de-escalation (n = 12 in ICO, n = 18 in ICH) and targeted treatment initiation (n = 7 in ICO, n = 21 in ICH). The PneumoSeq assay benefited the diagnosis and clinical management of both ICH and ICO pneumonia patients in real-world settings.Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate the clinical impact of PneumoSeq in 57 immunocompetent (ICO) and 75 immunocompromised (ICH) pneumonia patients. The value of PneumoSeq for both etiological and clinical impact investigation in pneumonia was assessed. Among the 276 potential pathogens detected with PneumoSeq in our cohort, 251 (90.9%) were cross-validated. Clinical diagnoses of the causative pathogens were obtained for 97 patients, 90.7% of which were supported by PneumoSeq. Compared to conventional testing, PneumoSeq suggested potentially missed diagnoses in 16.7% of cases (22/132), involving 48 additional pathogenic microorganisms. In 58 (43.9%) cases, PneumoSeq data led to antimicrobial treatment de-escalation (n = 12 in ICO, n = 18 in ICH) and targeted treatment initiation (n = 7 in ICO, n = 21 in ICH). The PneumoSeq assay benefited the diagnosis and clinical management of both ICH and ICO pneumonia patients in real-world settings.
Author Xie, Mingzhou
Chen, Rongchang
Li, Shaoqiang
Cheng, Linling
Li, Zhengtu
Li, Xiaolei
Xu, Teng
Zhong, Nanshan
He, Fusheng
Zhan, Yangqing
Guan, Wei-jie
Ye, Feng
AuthorAffiliation 3 Key Laboratory of Animal Gene Editing and Animal Cloning in Yunnan Province and College of Veterinary Medicine, Yunnan Agricultural University , Kunming , China
5 Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen Institute of Respiratory Diseases , Shenzhen , China
2 Vision Medicals Co., Ltd. , Guangzhou , China
4 Department of Thoracic Surgery, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China
1 State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease , Guangzhou , China
AuthorAffiliation_xml – name: 2 Vision Medicals Co., Ltd. , Guangzhou , China
– name: 1 State Key Laboratory of Respiratory Disease, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Health, National Clinical Research Center for Respiratory Disease , Guangzhou , China
– name: 4 Department of Thoracic Surgery, Guangzhou Institute for Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , China
– name: 3 Key Laboratory of Animal Gene Editing and Animal Cloning in Yunnan Province and College of Veterinary Medicine, Yunnan Agricultural University , Kunming , China
– name: 5 Department of Respiratory and Critical Care Medicine, First Affiliated Hospital of Southern University of Science and Technology, Second Clinical Medical College of Jinan University, Shenzhen People’s Hospital, Shenzhen Institute of Respiratory Diseases , Shenzhen , China
Author_xml – sequence: 1
  givenname: Yangqing
  surname: Zhan
  fullname: Zhan, Yangqing
– sequence: 2
  givenname: Teng
  surname: Xu
  fullname: Xu, Teng
– sequence: 3
  givenname: Fusheng
  surname: He
  fullname: He, Fusheng
– sequence: 4
  givenname: Wei-jie
  surname: Guan
  fullname: Guan, Wei-jie
– sequence: 5
  givenname: Zhengtu
  surname: Li
  fullname: Li, Zhengtu
– sequence: 6
  givenname: Shaoqiang
  surname: Li
  fullname: Li, Shaoqiang
– sequence: 7
  givenname: Mingzhou
  surname: Xie
  fullname: Xie, Mingzhou
– sequence: 8
  givenname: Xiaolei
  surname: Li
  fullname: Li, Xiaolei
– sequence: 9
  givenname: Rongchang
  surname: Chen
  fullname: Chen, Rongchang
– sequence: 10
  givenname: Linling
  surname: Cheng
  fullname: Cheng, Linling
– sequence: 11
  givenname: Nanshan
  surname: Zhong
  fullname: Zhong, Nanshan
– sequence: 12
  givenname: Feng
  surname: Ye
  fullname: Ye, Feng
BookMark eNp9UU1v1DAQtVARLaU_gFuOXLL1VxLnglRWLS0qggNI3KxZe7y4cuxiJ5X67_HuVohywAd75HnvzTy91-QopoiEvGV0JYQaz93kzWbFKWeroWN0EC_ICet72QrKfxz9VR-Ts1LuaD2S8nq_IsdC9lTwoTshn9bBR28gNJcPEBaYfYpNcg00n3GGLcZUx5T2AxS0zUUp8Ni4lJuvEZcpRV9hECtswji_IS8dhIJnT-8p-X51-W193d5--XizvrhtjZR8bu2md9xhZ4WzG2EMR7Rc9lIiMxQ6wZUcFY4jjoJx2_d1ZVXb3DEmR8eoOCU3B12b4E7fZz9BftQJvN5_pLzVkGdvAmrHu8EpaoRVQ7WsgHEAJZyhnWKsl1Xr_UHrftlMaE21kSE8E33eif6n3qYHraRiwyCqwLsngZx-LVhmPfliMASImJai6wIjHauFHZQdoCanUjK6P2MY1btI9T5SvYtUHyKtnOEfjvHzPqS6jQ__Yf4G5PinDg
CitedBy_id crossref_primary_10_3389_fcimb_2023_1112229
crossref_primary_10_1016_j_heliyon_2023_e23188
crossref_primary_10_3389_fcimb_2023_1135460
crossref_primary_10_3389_fcimb_2024_1439472
crossref_primary_10_3389_fcimb_2022_977591
crossref_primary_10_1007_s12223_024_01134_7
crossref_primary_10_1016_j_heliyon_2024_e31677
crossref_primary_10_1186_s12931_024_02991_z
crossref_primary_10_12677_acm_2025_151155
crossref_primary_10_3389_fmed_2022_952636
crossref_primary_10_1128_spectrum_03812_22
crossref_primary_10_1007_s40291_024_00727_9
crossref_primary_10_3389_fmicb_2022_927842
crossref_primary_10_1007_s15010_023_02144_2
crossref_primary_10_1016_j_heliyon_2024_e36405
crossref_primary_10_2147_IDR_S374906
crossref_primary_10_2147_IDR_S387134
crossref_primary_10_3389_fcimb_2024_1397733
crossref_primary_10_3389_fcimb_2022_904485
crossref_primary_10_1186_s12890_022_02300_8
crossref_primary_10_2147_IDR_S394265
crossref_primary_10_2147_IDR_S359596
crossref_primary_10_3389_fmicb_2022_819467
crossref_primary_10_3389_fcimb_2022_851891
crossref_primary_10_1016_j_cca_2022_10_008
crossref_primary_10_3389_fmed_2022_812698
crossref_primary_10_3389_fmed_2023_1195629
Cites_doi 10.3389/fmicb.2017.01069
10.1016/S0140-6736(15)60733-4
10.1111/crj.12674
10.1146/annurev-pathmechdis-012418-012751
10.1101/gr.171934.113
10.1152/ajplung.00476.2018
10.1186/s13059-016-0969-1
10.1007/s00134-019-05519-y
10.1111/crj.13369
10.1111/j.1469-0691.2012.03765.x
10.1093/cid/cix647
10.1007/s00134-019-05906-5
10.1093/cid/ciy723
10.1186/s40168-019-0678-6
10.1093/cid/ciy693
10.21037/jtd.2019.06.09
10.1097/MCP.0000000000000051
10.1093/bioinformatics/bty560
10.1007/s10096-021-04254-x
10.1093/bioinformatics/btp324
10.1128/mBio.01888-15
10.1038/s41582-020-0374-y
10.1093/cid/ciy802
10.1093/cid/cix881
10.1038/s41576-019-0113-7
10.1093/infdis/jiz151
10.1080/1040841X.2019.1681933
10.1038/nprot.2016.090
10.1016/j.jinf.2021.01.029
10.1093/cid/ciaa035
10.1101/gr.238170.118
10.1056/NEJMoa1803396
10.1016/S2213-2600(18)30345-X
10.1186/s13073-014-0114-2
10.1086/653033
ContentType Journal Article
Copyright Copyright © 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye.
Copyright © 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye. 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye
Copyright_xml – notice: Copyright © 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye.
– notice: Copyright © 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye. 2021 Zhan, Xu, He, Guan, Li, Li, Xie, Li, Chen, Cheng, Zhong and Ye
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fmicb.2021.751073
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList

CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-302X
ExternalDocumentID oai_doaj_org_article_f257f80c3d874608a12aa83fc0581164
PMC8481773
10_3389_fmicb_2021_751073
GrantInformation_xml – fundername: ;
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
ECGQY
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
O5R
O5S
OK1
PGMZT
RNS
RPM
7X8
5PM
ID FETCH-LOGICAL-c442t-db6f2fe5d3fdb3cc2eed24644e1c0a5328498e99e9312d6620084642f1149f103
IEDL.DBID M48
ISSN 1664-302X
IngestDate Wed Aug 27 01:28:14 EDT 2025
Thu Aug 21 18:16:00 EDT 2025
Fri Jul 11 04:37:18 EDT 2025
Thu Apr 24 23:06:23 EDT 2025
Tue Jul 01 04:33:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c442t-db6f2fe5d3fdb3cc2eed24644e1c0a5328498e99e9312d6620084642f1149f103
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Reviewed by: Bernard Joseph Hudson, New South Wales Health Pathology, Australia; Nicolas Leveque, University of Poitiers, France
This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology
These authors have contributed equally to this work
Edited by: David Andes, University of Wisconsin-Madison, United States
OpenAccessLink https://doaj.org/article/f257f80c3d874608a12aa83fc0581164
PMID 34603275
PQID 2579090083
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_f257f80c3d874608a12aa83fc0581164
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8481773
proquest_miscellaneous_2579090083
crossref_primary_10_3389_fmicb_2021_751073
crossref_citationtrail_10_3389_fmicb_2021_751073
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-09-16
PublicationDateYYYYMMDD 2021-09-16
PublicationDate_xml – month: 09
  year: 2021
  text: 2021-09-16
  day: 16
PublicationDecade 2020
PublicationTitle Frontiers in microbiology
PublicationYear 2021
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Kalantar (B18) 2019; 316
Dulanto Chiang (B10) 2020; 221
Prina (B25) 2015; 386
Letourneau (B19) 2014; 20
Shi (B28) 2019; 11
Chen (B6) 2018; 34
Chiu (B8) 2019; 20
(B32) 2020
Hogan (B17) 2020; 72
Avraham (B1) 2016; 11
Naccache (B23) 2014; 24
Wilson (B33) 2019; 380
Simner (B29) 2018; 66
Chen (B7) 2021; 15
Peng (B24) 2021; 82
Ramachandran (B26) 2020; 16
Miao (B21) 2018; 67
Ramirez (B27) 2017; 65
Forbes (B12) 2017; 8
Torres (B31) 2019; 45
Zinter (B36); 7
Azoulay (B3) 2020; 46
Di Pasquale (B9) 2019; 68
Sousa (B30) 2013; 19
Zinter (B35); 68
Fournier (B13) 2014; 6
Miller (B22) 2019; 29
Azoulay (B2) 2019; 7
Li (B20) 2009; 25
Han (B16) 2019; 45
Cao (B5) 2018; 12
Flygare (B11) 2016; 17
Zhang (B34) 2021; 40
Barriere (B4) 2010; 51
Gu (B15) 2019; 14
Goldberg (B14) 2015; 6
References_xml – volume: 8
  start-page: 1069
  year: 2017
  ident: B12
  article-title: Metagenomics: the next culture-independent game changer.
  publication-title: Front. Microbiol.
  doi: 10.3389/fmicb.2017.01069
– volume: 386
  start-page: 1097
  year: 2015
  ident: B25
  article-title: Community-acquired pneumonia.
  publication-title: Lancet
  doi: 10.1016/S0140-6736(15)60733-4
– volume: 12
  start-page: 1320
  year: 2018
  ident: B5
  article-title: Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese thoracic society, chinese medical association.
  publication-title: Clin. Respir. J.
  doi: 10.1111/crj.12674
– volume: 14
  start-page: 319
  year: 2019
  ident: B15
  article-title: Clinical metagenomic next-generation sequencing for pathogen detection.
  publication-title: Annu. Rev. Pathol.
  doi: 10.1146/annurev-pathmechdis-012418-012751
– volume: 24
  start-page: 1180
  year: 2014
  ident: B23
  article-title: A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples.
  publication-title: Genome Res.
  doi: 10.1101/gr.171934.113
– year: 2020
  ident: B32
  publication-title: The Top 10 Causes of Death.
– volume: 316
  start-page: L578
  year: 2019
  ident: B18
  article-title: Metagenomic comparison of tracheal aspirate and mini-bronchial alveolar lavage for assessment of respiratory microbiota.
  publication-title: Am. J. Physiol. Lung Cell Mol. Physiol.
  doi: 10.1152/ajplung.00476.2018
– volume: 17
  start-page: 111
  year: 2016
  ident: B11
  article-title: Taxonomer: an interactive metagenomics analysis portal for universal pathogen detection and host mRNA expression profiling.
  publication-title: Genome Biol.
  doi: 10.1186/s13059-016-0969-1
– volume: 45
  start-page: 159
  year: 2019
  ident: B31
  article-title: Challenges in severe community-acquired pneumonia: a point-of-view review.
  publication-title: Intens. Care Med.
  doi: 10.1007/s00134-019-05519-y
– volume: 15
  start-page: 815
  year: 2021
  ident: B7
  article-title: Clinical and etiological analysis of co-infections and secondary infections in COVID-19 patients: an observational study.
  publication-title: Clin. Respir. J.
  doi: 10.1111/crj.13369
– volume: 19
  start-page: 187
  year: 2013
  ident: B30
  article-title: Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome.
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1111/j.1469-0691.2012.03765.x
– volume: 65
  start-page: 1806
  year: 2017
  ident: B27
  article-title: Adults hospitalized with pneumonia in the united states: incidence, epidemiology, and mortality.
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/cix647
– volume: 46
  start-page: 298
  year: 2020
  ident: B3
  article-title: Diagnosis of severe respiratory infections in immunocompromised patients.
  publication-title: Intensive Care Med.
  doi: 10.1007/s00134-019-05906-5
– volume: 68
  start-page: 1482
  year: 2019
  ident: B9
  article-title: Prevalence and etiology of community-acquired pneumonia in immunocompromised patients.
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciy723
– volume: 7
  start-page: 62
  ident: B36
  article-title: Towards precision quantification of contamination in metagenomic sequencing experiments.
  publication-title: Microbiome
  doi: 10.1186/s40168-019-0678-6
– volume: 67
  start-page: S231
  year: 2018
  ident: B21
  article-title: Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice.
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciy693
– volume: 11
  start-page: 2581
  year: 2019
  ident: B28
  article-title: Chinese guidelines for the diagnosis and treatment of hospital-acquired pneumonia and ventilator-associated pneumonia in adults (2018 Edition).
  publication-title: J. Thorac. Dis.
  doi: 10.21037/jtd.2019.06.09
– volume: 20
  start-page: 272
  year: 2014
  ident: B19
  article-title: Pneumonia in the immunocompromised host.
  publication-title: Curr. Opin. Pulm Med.
  doi: 10.1097/MCP.0000000000000051
– volume: 34
  start-page: i884
  year: 2018
  ident: B6
  article-title: fastp: an ultra-fast all-in-one FASTQ preprocessor.
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bty560
– volume: 40
  start-page: 1933
  year: 2021
  ident: B34
  article-title: Application of metagenomic next-generation sequencing in the diagnosis and treatment guidance of Pneumocystis jirovecii pneumonia in renal transplant recipients.
  publication-title: Eur. J. Clin. Microbiol. Infect. Dis.
  doi: 10.1007/s10096-021-04254-x
– volume: 25
  start-page: 1754
  year: 2009
  ident: B20
  article-title: Fast and accurate short read alignment with Burrows-Wheeler transform.
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btp324
– volume: 6
  start-page: e01888
  year: 2015
  ident: B14
  article-title: Making the leap from research laboratory to clinic: challenges and opportunities for next-generation sequencing in infectious disease diagnostics.
  publication-title: mBio
  doi: 10.1128/mBio.01888-15
– volume: 16
  start-page: 547
  year: 2020
  ident: B26
  article-title: Metagenomics for neurological infections - expanding our imagination.
  publication-title: Nat. Rev. Neurol.
  doi: 10.1038/s41582-020-0374-y
– volume: 68
  start-page: 1847
  ident: B35
  article-title: Pulmonary metagenomic sequencing suggests missed infections in immunocompromised children.
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciy802
– volume: 66
  start-page: 778
  year: 2018
  ident: B29
  article-title: Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases.
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/cix881
– volume: 20
  start-page: 341
  year: 2019
  ident: B8
  article-title: Clinical metagenomics.
  publication-title: Nat. Rev. Genet.
  doi: 10.1038/s41576-019-0113-7
– volume: 221
  start-page: S331
  year: 2020
  ident: B10
  article-title: From the pipeline to the bedside: advances and challenges in clinical metagenomics.
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jiz151
– volume: 45
  start-page: 668
  year: 2019
  ident: B16
  article-title: mNGS in clinical microbiology laboratories: on the road to maturity.
  publication-title: Crit. Rev. Microbiol.
  doi: 10.1080/1040841X.2019.1681933
– volume: 11
  start-page: 1477
  year: 2016
  ident: B1
  article-title: A highly multiplexed and sensitive RNA-seq protocol for simultaneous analysis of host and pathogen transcriptomes.
  publication-title: Nat. Protoc.
  doi: 10.1038/nprot.2016.090
– volume: 82
  start-page: 22
  year: 2021
  ident: B24
  article-title: Metagenomic next-generation sequencing for the diagnosis of suspected pneumonia in immunocompromised patients.
  publication-title: J. Infect.
  doi: 10.1016/j.jinf.2021.01.029
– volume: 72
  start-page: 239
  year: 2020
  ident: B17
  article-title: Clinical impact of metagenomic next-generation sequencing of plasma cell-free DNA for the diagnosis of infectious diseases: a multicenter retrospective cohort study.
  publication-title: Clin. Infect. Dis.
  doi: 10.1093/cid/ciaa035
– volume: 29
  start-page: 831
  year: 2019
  ident: B22
  article-title: Laboratory validation of a clinical metagenomic sequencing assay for pathogen detection in cerebrospinal fluid.
  publication-title: Genome Res.
  doi: 10.1101/gr.238170.118
– volume: 380
  start-page: 2327
  year: 2019
  ident: B33
  article-title: Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis.
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMoa1803396
– volume: 7
  start-page: 173
  year: 2019
  ident: B2
  article-title: Acute respiratory failure in immunocompromised adults.
  publication-title: Lancet Respir Med.
  doi: 10.1016/S2213-2600(18)30345-X
– volume: 6
  start-page: 114
  year: 2014
  ident: B13
  article-title: Clinical detection and characterization of bacterial pathogens in the genomics era.
  publication-title: Genome Med.
  doi: 10.1186/s13073-014-0114-2
– volume: 51
  start-page: S4
  year: 2010
  ident: B4
  article-title: Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective.
  publication-title: Clin. Infect. Dis.
  doi: 10.1086/653033
SSID ssj0000402000
Score 2.466588
Snippet Clinical value of metagenomic next-generation sequencing (mNGS) in pneumonia management is still controversial. A prospective study was conducted to evaluate...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 751073
SubjectTerms cytomegalovirus
metagenomic next-generation sequence
Microbiology
pathogens
pneumocystis jirovecii
pneumonia
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La8MwDDZjMNhl7Mm6Fx7sNMjm-JHEx3W0lELHDiv0ZhzHZoWSjrU99N9PStLSXLbLrolFHEm29GH5EyEPLMXrlTKJkoQXkcyTEAFWSSIp84Ip5qyyeFF49JYMxnI4UZOdVl9YE1bTA9eKew7gUyFjThRZKhOW2Zhbm4ngmMpiyPVx94WYtwOmqj0YYRFrjjEBhWkw09TlgAd5_JSCH6aiFYgqvv5WktkukdyJOf1jctQki_SlnuQJ2fPlKTmo20euz8iwIfWc0d6Ws5vOA7V05JcW2VdhNouoC4GqoGAHu6aQotL30q_A-aYwbFv7ck7G_d7H6yBqeiNETkq-jPD2HA9eFSIUuXCOQ6zjEpIbHztmlYCoozOvtdci5gUYAonzAWsEwD86xExckP1yXvpLQnlehAzEhI6dBICSMZUHkOBpsNwp1SFsoyjjGuJw7F8xMwAgULem0q1B3Zpatx3yuBX5qlkzfhvcRe1vByLhdfUA3MA0bmD-coMOud_YzsACwVMPW_r5amFAUDONqWaHpC2jtr7YflNOPyuqbWw2kKbi6j-meE0O8a-x2CRObsj-8nvlbyGjWeZ3lfP-AFKA8gk
  priority: 102
  providerName: Directory of Open Access Journals
Title Clinical Evaluation of a Metagenomics-Based Assay for Pneumonia Management
URI https://www.proquest.com/docview/2579090083
https://pubmed.ncbi.nlm.nih.gov/PMC8481773
https://doaj.org/article/f257f80c3d874608a12aa83fc0581164
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Li9RAEC7WFcGL-MTxsbTgScjS704OIq7suiyMeHBgbk2n060DQ0bnAc6_tyrJDAYWwUsgSVceVd2p-tJdXwG85Y7SK7UtrJVNoWubC8QqttC6brjhMZhAicLTL_Z6pm_mZn4Ch_JWgwI3t0I7qic1Wy_Pf__af8AB_54QJ_pbtMAi1gj1pDh32MWcugN30TE5GqfTIdrvPsyElbqkFGEtzQfIeT_PeftVRp6qI_QfRaHjNZR_OaWrh_BgiCbZx978j-AktY_hXl9fcv8EbgbWzyW7PJJ6s1VmgU3TNhA9Kz7NprhAT9YwNFTYM4xh2dc27bB3LrDZcXHMU5hdXX77dF0MxROKqLXcFpReJ3MyjcpNrWKU6AylxugniciDUeiWqjJVVaqUkA1aipj1EYxkBEhVFlw9g9N21abnwGTd5BLFVCUiqlWX3NQZJaTLQUZjJsAPivJxYBanAhdLjwiDdOs73XrSre91O4F3R5GfPa3GvxpfkPaPDYkRuzuwWn_3wwDzGb89ueRRNaXTlpdByBBKlSM3pUBMOIE3B9t5HEE0LRLatNptPApWvKJYdAJuZNTRHcdn2sWPjoubqhE4p178z_u8hPu0R6tOhH0Fp9v1Lr3G0GZbn3W_BHD7eS7Ous77B0_Q9mY
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+Evaluation+of+a+Metagenomics-Based+Assay+for+Pneumonia+Management&rft.jtitle=Frontiers+in+microbiology&rft.au=Zhan%2C+Yangqing&rft.au=Xu%2C+Teng&rft.au=He%2C+Fusheng&rft.au=Guan%2C+Wei-jie&rft.date=2021-09-16&rft.issn=1664-302X&rft.eissn=1664-302X&rft.volume=12&rft_id=info:doi/10.3389%2Ffmicb.2021.751073&rft.externalDBID=n%2Fa&rft.externalDocID=10_3389_fmicb_2021_751073
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-302X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-302X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-302X&client=summon